INC Research Holdings, Inc. is a global contract research organization (CRO). The Company is focused on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services. The Company's Clinical Development Services segment offers all clinical development services, including full-service global studies, as well as ancillary services, such as clinical monitoring, investigator recruitment, patient recruitment, data management, study reports to assist customers with their drug development process, quality assurance audits and specialized consulting services. The Company's Phase I Services segment focuses on clinical development services for Phase I trials, whic... (Source: SEC reports)
Competitor - 1/8
Which company is more competitive with INC Research?
SAN FRANCISCO, March 28, 2017 /PRNewswire/ --Â goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today results from its ongoing partnership with INC Research (NASDAQ: [...]